Case Report


Massive renal pelvis urothelial carcinoma with invasion of the descending colon and cutaneous metastases: A case report and literature review

,  ,  ,  

1 Department of Urology, Taitung Mackay Memorial Hospital, Taitung, Taiwan

2 Department of Medicine, Mackay Medical College, New Taipei City, Taiwan

3 Department of Colorectal Surgery, Taitung Mackay Memorial Hospital, Taitung, Taiwan

4 Department of General Surgery, Taitung Mackay Memorial Hospital, Taitung, Taiwan

5 Department of Pathology, Taitung Mackay Memorial Hospital, Taitung, Taiwan

Address correspondence to:

Ti-Yuan Yang

No. 1, Ln. 303, Changsha St., Taitung City, Taitung County,

Taiwan

Message to Corresponding Author


Article ID: 100135Z12TY2024

doi: 10.5348/100135Z12TY2024CR

Access full text article on other devices

Access PDF of article on other devices

How to cite this article

Yang TY, Hung YT, Huang SS, Chu CY. Massive renal pelvis urothelial carcinoma with invasion of the descending colon and cutaneous metastases: A case report and literature review. J Case Rep Images Surg 2024;10(1):34–38.

ABSTRACT


Introduction: Skin metastases and gastrointestinal tract involvement in upper tract urothelial carcinoma (UTUC) are uncommon and associated with an adverse prognosis. This report details a case of extensive urothelial carcinoma originating from the renal pelvis, invading the descending colon, and presenting with cutaneous metastases.

Case Report: A 63-year-old male patient visited the emergency department on the account of sudden onset of severe left upper abdominal pain and nausea. The computed tomography (CT) revealed soft tissue density at the mesentery adjacent to the left kidney with the involvement of the distal transverse colon. The patient underwent left radical nephroureterectomy, left hemicolectomy, and bladder cuff excision. Six weeks postoperatively, left inguinal cutaneous metastases, approximately 4 cm, were excised. Due to renal dysfunction, the patient received gemcitabine and carboplatin chemotherapy, followed by pembrolizumab for the cutaneous metastatic disease. Follow-up imaging showed no evidence of recurrence or metastasis 15 months postoperatively.

Conclusion: In cases of advanced UTUC, a multidisciplinary approach combining surgical intervention, chemotherapy, and immunotherapy can alleviate symptoms and potentially improve survival rates. This integrative treatment strategy highlights the importance of a multidisciplinary approach in managing complex oncological cases.

Keywords: Cutaneous metastases, Nephroureterectomy, Upper tract urothelial carcinoma

SUPPORTING INFORMATION


Author Contributions

Ti-Yuan Yang - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Yu-Ting Hung - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Revising it critically for important intellectual content, Final approval of the version to be published

Shou-Sen Huang - Substantial contributions to conception and design, Acquisition of data, Revising it critically for important intellectual content, Final approval of the version to be published

Chia-Ying Chu - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Revising it critically for important intellectual content, Final approval of the version to be published

Guarantor of Submission

The corresponding author is the guarantor of submission.

Source of Support

None

Consent Statement

Written informed consent was obtained from the patient for publication of this article.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Conflict of Interest

Authors declare no conflict of interest.

Copyright

© 2024 Ti-Yuan Yang et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.